Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax

Mol Cell. 2020 Feb 20;77(4):901-912.e9. doi: 10.1016/j.molcel.2019.12.025. Epub 2020 Jan 27.

Abstract

Current models of apoptosis regulation by the Bcl-2 family of proteins postulate that heterodimeric interactions between family members determine whether Bax and Bak are activated to trigger cell death. Thus, the relative abundance and binding affinities between pro- and anti-apoptotic proteins determines the outcome of these interactions. Examination of these interactions using purified mitochondria and liposomes with full-length recombinant proteins revealed that Bcl-xL inhibits apoptosis as a higher-order complex that binds multiple BH3 proteins. Allosteric regulation of this complex by the BH3 sensitizer Bad confers switch-like activity to the indirect activation of Bax. The BH3 activator cBid sequestered by Bcl-xL complexes changes from an inactive to an active form while bound to a Bcl-xL complex only when Bad is also bound. Bcl-xL complexes enable Bad to function as a non-competitive inhibitor of Bcl-xL and allosterically activate cBid, dramatically enhancing the pro-apoptotic potency of Bad.

Keywords: Bad; Bax; Bcl-2 family; Bcl-xL complexes; Bid; MOMP; allosteric activation; apoptosis; mitochondria; switch-like activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Animals
  • Apoptosis
  • BH3 Interacting Domain Death Agonist Protein / metabolism
  • Cell Line
  • Humans
  • Mice
  • Mitochondrial Membranes / metabolism
  • bcl-2-Associated X Protein / metabolism*
  • bcl-Associated Death Protein / metabolism
  • bcl-X Protein / chemistry
  • bcl-X Protein / metabolism*

Substances

  • BH3 Interacting Domain Death Agonist Protein
  • bcl-2-Associated X Protein
  • bcl-Associated Death Protein
  • bcl-X Protein

Grants and funding